Biotechnology & Pharmaceuticals Report

The Wall Street Transcript has just published its Biotechnology & Pharmaceuticals Report, a report offering a timely review of the sector to serious investors and industry executives. This 36-page feature contains industry commentary through in-depth interviews with 3 leading Analysts and top management from 7 Sector Firms. Topics covered: Clinical, Financial & Regulatory Risks To Drug Development - Easing Capital Markets - Managing Inherent Volatility - FDA Approval Process - Small- & Mid-Cap M&A Rally - Basket Investment Approach - Impact Of Health Care Reform - Therapeutic Cardiovascular Plays - Investable Trend In Antibody Technology